Voyager Therapeutics VYGR
NASDAQ VYGR
$2.69 +0.05 (+1.89%)
As of: Sep 30, 2026 · 2:58 PM EDT

Voyager Therapeutics (VYGR) EV to EBIT (2020 - 2024)

Updated

Voyager Therapeutics' EV to EBIT came in at -2.90 for Q3 2024, compared with 2.01 a year earlier.

Analysis

Voyager Therapeutics (VYGR) EV to EBIT (2020 - 2024) Analysis & Trends

Over the trailing twelve months to Sep 30, 2024, Voyager Therapeutics reported EV to EBIT of -113.25; for FY2023, it came in at 1.15.

  • Going back by year, EV to EBIT was 3.14 in FY2020.
  • The Q3 2024 figure represents the lowest quarterly EV to EBIT in data going back to Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Voyager Therapeutics 161.76 Mn -501.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -2.90
Dec 31, 2023 1.15
Sep 30, 2023 2.01
Jun 30, 2023 2.61
Mar 31, 2023 0.66
Jun 30, 2021 1.97
Mar 31, 2021 0.59
Dec 31, 2020 3.14
Sep 30, 2020 5.29
API Access

Voyager Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=VYGR&period=max&api_key=YOUR_API_KEY